Cytokine profiling of young overweight and obese female African American adults with prediabetes

Cytokine

Volumn 64, Issue 1, 2013, Pages 310-315

  Lucas, Rudolf ^a,b   Parikh, Samip J ^a   Sridhar, Supriya ^a   Guo, De Huang ^a   Bhagatwala, Jigar ^a   Dong, Yutong ^a   Caldwell, Ruth ^a   Mellor, Andrew ^a   Caldwell, William ^a   Zhu, Haidong ^a   Dong, Yanbin ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b AUGUSTA UNIVERSITY   (United States)

Author keywords

African American; Cytokines; HbA1c; Obesity; Prediabetes

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN A1C; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AFRICAN AMERICAN; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; OBESITY; PRIORITY JOURNAL;

ANIMALIA;

AFRICAN AMERICAN; CARDIOVASCULAR DISEASES; CVD; CYTOKINES; GM-CSF; GRANULOCYTE-MONOCYTE COLONY-STIMULATING FACTOR; HBA1C; IFN; IL; INTERFERON; INTERLEUKIN; OBESITY; PREDIABETES; T2D; TNF; TUMOR NECROSIS FACTOR; TYPE 2 DIABETES;

ADOLESCENT; ADULT; AFRICAN AMERICANS; BODY SIZE; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFLAMMATION; MIDDLE AGED; OBESITY; PREDIABETIC STATE; YOUNG ADULT;

EID: 84883559841     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.05.025     Document Type: Article

References (59)

1. Grundy S.M. Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 2012, 59:635-643.
2. Standards of medical care in diabetes-2012. Diabetes care. 2012; p. 35.
3. Zhang X., Gregg E.W., Williamson D.F., Barker L.E., Thomas W., Bullard K.M., et al. A1C level and future risk of diabetes: a systematic review. Diabetes Care 2010, 33:1665-1673.
4. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: US. Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
5. Gabir M.M., Hanson R.L., Dabelea D., Imperatore G., Roumain J., Bennett P.H., et al. Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care 2000, 23:1113-1118.
6. Garber A.J., Handelsman Y., Einhorn D., Bergman D.A., Bloomgarden Z.T., Fonseca V., et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract 2008, 14:933-946.
7. Haffner S.M., Stern M.P., Gruber M.K., Hazuda H.P., Mitchell B.D., Patterson J.K. Microalbuminuria. Potential marker for increased cardiovascular risk factors in nondiabetic subjects?. Arteriosclerosis 1990, 10:727-731.
8. Plantinga L.C., Crews D.C., Coresh J., Miller E.R., Saran R., Yee J., et al. Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. Clin J Am Soc Nephrol 2010, 5:673-682.
9. Player M.S., Diaz V.A., Mainous A.G., Gregorie S.H., Knoll M.E., Everett C.J. Ethnic differences in the relationship of prediabetes with the presence of target-organ disease. Diabetes Metab 2011, 37:403-409.
10. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007, 115:169-171.
11. Zhou Q.P., Remsburg R., Caufield K., Itote E.W. Lifestyle behaviors, chronic diseases, and ratings of health between black and white adults with pre-diabetes. Diabetes Educator 2012, 38:219-228.
12. Hu F.B., Meigs J.B., Li T.Y., Rifai N., Manson J.E. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004, 53:693-700.
13. Pickup J.C., Mattock M.B., Chusney G.D., Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997, 40:1286-1292.
14. Bertoni A.G., Burke G.L., Owusu J.A., Carnethon M.R., Vaidya D., Barr R.G., et al. Inflammation and the incidence of type 2 diabetes: the multi-ethnic study of atherosclerosis (MESA). Diabetes Care. 2010, 33:804-810.
15. Gupta S., Maratha A., Gajanayake T., Siednienko J., Natarajan A., Hoashi S., et al. Cytokine profiling of pre-diabetic patients. Presented at Society for Endocrinology BES 2011, Birmingham, UK. Endocr Abstr 2011, 2011:25.
16. Lin J., Zhang M., Song F., Qin J., Wang R., Yao P., et al. Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population. Diabetes Metab Res Rev 2009, 25:219-223.
17. Cardellini M., Andreozzi F., Laratta E., Marini M.A., Lauro R., Hribal M.L., et al. Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians. Diabetes Metab Res Rev 2007, 23:141-145.
18. Konukoglu D., Hatemi H., Bayer H., Bagriacik N. Relationship between serum concentrations of interleukin-6 and tumor necrosis factor alpha in female Turkish subjects with normal and impaired glucose tolerance. Hormone Metab Res=Hormon- und Stoffwechselforschung=Hormones et Metab 2006, 38:34-37.
19. Choi K.M., Lee J., Lee K.W., Seo J.A., Oh J.H., Kim S.G., et al. Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance. Diabetes Res Clin Pract 2004, 64:99-106.
20. Straczkowski M., Kowalska I., Nikolajuk A., Dzienis-Straczkowska S., Szelachowska M., Kinalska I. Plasma interleukin eight concentrations in obese subjects with impaired glucose tolerance. Cardiovasc Diabetol 2003, 2:5.
21. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067-2072.
22. Lucas R., Sridhar S., Rick F.G., Gorshkov B., Umapathy N.S., Yang G., et al. Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema. Proc Natl Acad Sci USA 2012, 109:2084-2089.
23. Wong H.L., Pfeiffer R.M., Fears T.R., Vermeulen R., Ji S., Rabkin C.S. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev 2008, 17:3450-3456.
24. Elshal M.F., McCoy J.P. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 2006, 38:317-323.
25. Richens J.L., Urbanowicz R.A., Metcalf R., Corne J., O'Shea P., Fairclough L. Quantitative validation and comparison of multiplex cytokine kits. J Biomol Scr 2010, 15:562-568.
26. Cai D. One step from prediabetes to diabetes: hypothalamic inflammation?. Endocrinology 2012, 153:1010-1013.
27. Gupta A.K., Johnson W.D. Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu. J Inflamm (Lond) 2010, 7:36.
28. Alexandraki K., Piperi C., Kalofoutis C., Singh J., Alaveras A., Kalofoutis A. Inflammatory process in type 2 diabetes: The role of cytokines. Ann NY Acad Sci 2006, 1084:89-117.
29. Pickup J.C., Chusney G.D., Thomas S.M., Burt D. Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes. Life Sci 2000, 67:291-300.
30. Arnalich F., Hernanz A., Lopez-Maderuelo D., Pena J.M., Camacho J., Madero R., et al. Enhanced acute-phase response and oxidative stress in older adults with type II diabetes. Hormone Metab Res=Hormon- und Stoffwechselforschung=Hormones et Metab 2000, 32:407-412.
31. Popko K., Gorska E., Stelmaszczyk-Emmel A., Plywaczewski R., Stoklosa A., Gorecka D., et al. Proinflammatory cytokines Il-6 and TNF-alpha and the development of inflammation in obese subjects. Eur J Med Res 2010, 15(Suppl. 2):120-122.
32. Nishizawa T., Bornfeldt K.E. Diabetic vascular disease and the potential role of macrophage glucose metabolism. Ann Med 2011.
33. Surendar J., Mohan V., Pavankumar N., Babu S., Aravindhan V. Increased levels of serum granulocyte-macrophage colony-stimulating factor is associated with activated peripheral dendritic cells in type 2 diabetes subjects (CURES-99). Diabetes Technol Ther 2012, 14:344-349.
34. Musilli C., Paccosi S., Pala L., Gerlini G., Ledda F., Mugelli A., et al. Characterization of circulating and monocyte-derived dendritic cells in obese and diabetic patients. Mol Immunol 2011, 49:234-238.
35. Molfino N.A., Gossage D., Kolbeck R., Parker J.M., Geba G.P. Molecular and clinical rationale for therapeutic targeting of interleukin-5 and its receptor. Clin Exp Allergy 2012, 42:712-737.
36. Fukui M., Tanaka M., Hamaguchi M., Senmaru T., Sakabe K., Shiraishi E., et al. Eosinophil count is positively correlated with albumin excretion rate in men with type 2 diabetes. Clin J Am Soc Nephrol 2009, 4:1761-1765.
37. Luk A.O., Wang Y., Ma R.C., Tam C.H., Ng M.C., Lam V., et al. Predictive role of polymorphisms in interleukin-5 receptor alpha-subunit, lipoprotein lipase, integrin A2 and nitric oxide synthase genes on ischemic stroke in type 2 diabetes - an 8-year prospective cohort analysis of 1327 Chinese patients. Atherosclerosis 2011, 215:130-135.
38. Mazzucchelli R.I., Riva A., Durum S.K. The human IL-7 receptor gene: deletions, polymorphisms and mutations. Semin Immunol 2012, 24:225-230.
39. Hoe E., McKay F.C., Schibeci S.D., Gandhi K., Heard R.N., Stewart G.J., et al. Functionally significant differences in expression of disease-associated IL-7 receptor alpha haplotypes in CD4 T cells and dendritic cells. J Immunol 2010, 184:2512-2517.
40. Lee L.F., Logronio K., Tu G.H., Zhai W., Ni I., Mei L., et al. Anti-IL-7 receptor-alpha reverses established type 1 diabetes in nonobese diabetic mice by modulating effector T-cell function. Proc Natl Acad Sci USA 2012.
41. Penaranda C., Kuswanto W., Hofmann J., Kenefeck R., Narendran P., Walker L.S., et al. IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells. Proc Natl Acad Sci USA 2012.
42. Moon J.Y., Jeong K.H., Lee T.W., Ihm C.G., Lim S.J., Lee S.H. Aberrant recruitment and activation of T cells in diabetic nephropathy. Am J Nephrol 2012, 35:164-174.
43. Gustavsson C.G., Agardh C.D. Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range. Euro Heart j 2004, 25:2120-2124.
44. Martins R.A., Jones J.G., Cumming S.P., Coelho e Silva M.J., Teixeira A.M., Verissimo M.T. Glycated hemoglobin and associated risk factors in older adults. Cardiovasc Diabetol 2012, 11:13.
45. Wieser V., Moschen A.R., Tilg H. Inflammation, cytokines and insulin resistance: a clinical perspective. Arch Immunol et Ther Ex 2013, 61:119-125.
46. Samuel V.T., Shulman G.I. Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148:852-871.
47. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.W., Karin M., et al. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 2001, 293:1673-1677.
48. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
49. Kim D.H., Sandoval D., Reed J.A., Matter E.K., Tolod E.G., Woods S.C., et al. The role of GM-CSF in adipose tissue inflammation. Am J Physiol Endocrinol Metab 2008, 295:E1038-E1046.
50. Bahramian N., Ostergren-Lunden G., Bondjers G., Olsson U. Fatty acids induce increased granulocyte macrophage-colony stimulating factor secretion through protein kinase C-activation in THP-1 macrophages. Lipids 2004, 39:243-249.
51. Lee J.Y., Muenzberg H., Gavrilova O., Reed J.A., Berryman D., Villanueva E.C., et al. Loss of cytokine-STAT5 signaling in the CNS and pituitary gland alters energy balance and leads to obesity. PloS One 2008, 3:e1639.
52. Lucas S., Taront S., Magnan C., Fauconnier L., Delacre M., Macia L., et al. Interleukin-7 regulates adipose tissue mass and insulin sensitivity in high-fat diet-fed mice through lymphocyte-dependent and independent mechanisms. PloS one 2012, 7:e40351.
53. Molofsky A.B., Nussbaum J.C., Liang H.E., Van Dyken S.J., Cheng L.E., Mohapatra A., et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J Ex Med 2013, 210:535-549.
54. Major C.D., Wolf B.A. Interleukin-1beta stimulation of c-Jun NH(2)-terminal kinase activity in insulin-secreting cells: evidence for cytoplasmic restriction. Diabetes 2001, 50:2721-2728.
55. Zhou W., Zhang F., Aune T.M. Either IL-2 or IL-12 is sufficient to direct Th1 differentiation by nonobese diabetic T cells. J Immunol 2003, 170:735-740.
56. Bruun J.M., Verdich C., Toubro S., Astrup A., Richelsen B. Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men. Eur J Endocrin/Eur Fed Endocrine Soc 2003, 148:535-542.
57. Tsiavou A., Hatziagelaki E., Chaidaroglou A., Koniavitou K., Degiannis D., Raptis S.A. Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+ and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA). Cytokine 2005, 31:135-141.
58. Herder C., Baumert J., Zierer A., Roden M., Meisinger C., Karakas M., et al. Immunological and cardiometabolic risk factors in the prediction of type 2 diabetes and coronary events: MONICA/KORA Augsburg case-cohort study. PloS one 2011, 6:e19852.
59. Nicholson W., Wang N.Y., Baptiste-Roberts K., Chang Y.T., Powe N.R. Association between adiponectin and tumor necrosis factor-alpha levels at eight to fourteen weeks gestation and maternal glucose tolerance: the Parity, inflammation, and diabetes study. J women's Health 2013, 22:259-266.